These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 6606038

  • 21. Use of danazol for treatment of corticosteroid-resistant immune-mediated thrombocytopenia in a dog.
    Bloom JC, Meunier LD, Thiem PA, Sellers TS.
    J Am Vet Med Assoc; 1989 Jan 01; 194(1):76-8. PubMed ID: 2914797
    [Abstract] [Full Text] [Related]

  • 22. Danazol's failure to suppress autoimmunity in NZB/NZW F1 mice.
    Roubinian JR, Talal N, Greenspan JS, Goodman JR, Nussenzweig V.
    Arthritis Rheum; 1979 Dec 01; 22(12):1399-1402. PubMed ID: 316328
    [No Abstract] [Full Text] [Related]

  • 23. Hyperprolactinemia in males with systemic lupus erythematosus.
    Mok CC, Lau CS, Lee KW, Wong RW.
    J Rheumatol; 1998 Dec 01; 25(12):2357-63. PubMed ID: 9858430
    [Abstract] [Full Text] [Related]

  • 24. Systemic lupus erythematosus: two patients treated with danazol.
    Morley KD, Parke A, Hughes GR.
    Br Med J (Clin Res Ed); 1982 May 15; 284(6327):1431-2. PubMed ID: 6805552
    [Abstract] [Full Text] [Related]

  • 25. Immunologic findings, thrombocytopenia and disease activity in lupus nephritis.
    Clark WF, Linton AL, Cordy PE, Keown PE, Lohmann RC, Lindsay RM.
    Can Med Assoc J; 1978 Jun 10; 118(11):1391-5. PubMed ID: 350367
    [Abstract] [Full Text] [Related]

  • 26. Hyperglucagonaemia and treatment with danazol for systemic lupus erythematosus.
    David J.
    Br Med J (Clin Res Ed); 1985 Oct 26; 291(6503):1170-1. PubMed ID: 3931840
    [No Abstract] [Full Text] [Related]

  • 27. [Hereditary angioneurotic edema: therapeutic aspects].
    Sastre Castillo A, Lahoz Navarro F, Azofra García J, Sastre Domínguez J, Gómez Gómez B.
    Rev Clin Esp; 1985 Oct 26; 175(5-6):229-31. PubMed ID: 6535207
    [No Abstract] [Full Text] [Related]

  • 28. Remissions induced in hereditary angioneurotic edema with an attenuated androgen (danazol): correlation between concentrations of C1-inhibitor and the forth and second components of complement.
    Pitts JS, Donaldson VH, Forristal J, Wyatt RJ.
    J Lab Clin Med; 1978 Oct 26; 92(4):501-7. PubMed ID: 712189
    [Abstract] [Full Text] [Related]

  • 29. Management of hereditary angio-oedema with low-dose danazol.
    MacFarlane JT, Davies D.
    Br Med J (Clin Res Ed); 1981 Apr 18; 282(6272):1275. PubMed ID: 6784814
    [No Abstract] [Full Text] [Related]

  • 30. [Long-term treatment with i.v. immunoglobulin in the therapy of systemic lupus erythematosus].
    Francioni C, Fioravanti A, Gelli R, Megale F, Marcolongo R.
    Recenti Prog Med; 1993 Oct 18; 84(10):679-86. PubMed ID: 8235034
    [Abstract] [Full Text] [Related]

  • 31. Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study.
    Aringer M, Graninger WB, Steiner G, Smolen JS.
    Arthritis Rheum; 2004 Oct 18; 50(10):3161-9. PubMed ID: 15476222
    [Abstract] [Full Text] [Related]

  • 32. [Relationship of renal histopathology to immunoglobulin classes and complement fixation of anti-native DNA antibodies and components of immune complexes in patients with systemic lupus erythematosus (author's transl)].
    Hashimoto H, Utagawa Y, Yamagata J, Okada T, Shiokawa Y, Suzuki S, Tomiyama T.
    Ryumachi; 1981 Sep 18; 21(5):366-74. PubMed ID: 6977194
    [No Abstract] [Full Text] [Related]

  • 33. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K.
    Scand J Rheumatol; 2007 Sep 18; 36(4):291-8. PubMed ID: 17763207
    [Abstract] [Full Text] [Related]

  • 34. [Intravenous administration of immunoglobulins in systemic lupus erythematosus: review of the literature and initial clinical experiences].
    Pirner K, Rubbert A, Burmester GR, Kalden JR, Manger B.
    Infusionsther Transfusionsmed; 1993 Apr 18; 20 Suppl 1():131-5; discussion 136. PubMed ID: 8499742
    [Abstract] [Full Text] [Related]

  • 35. [Hematological abnormalities in systemic lupus erythematosus and clinical significance thereof: comparative analysis of 236 cases].
    Chen JL, Huang XM, Zeng XJ, Wang Y, Zhou MX, Ma YH, Li RS, Shen T.
    Zhonghua Yi Xue Za Zhi; 2007 May 22; 87(19):1330-3. PubMed ID: 17727778
    [Abstract] [Full Text] [Related]

  • 36. Treatment with danazol and plasma glucagon concentration.
    Williams G, Lofts F, Fuessl H, Bloom S.
    Br Med J (Clin Res Ed); 1985 Oct 26; 291(6503):1155-6. PubMed ID: 3931833
    [Abstract] [Full Text] [Related]

  • 37. Effect of danazol on lupus-erythematosus-like disease in hereditary angioneurotic oedema.
    Donaldson VH, Hess EV.
    Lancet; 1980 Nov 22; 2(8204):1145. PubMed ID: 6107762
    [No Abstract] [Full Text] [Related]

  • 38. Inherited complement deficiency states and SLE.
    Rynes RI.
    Clin Rheum Dis; 1982 Apr 22; 8(1):29-47. PubMed ID: 6288318
    [No Abstract] [Full Text] [Related]

  • 39. Tendon rupture in systemic lupus erythematosus.
    Khan MA, Ballou SP.
    J Rheumatol; 1981 Apr 22; 8(2):308-10. PubMed ID: 6971935
    [Abstract] [Full Text] [Related]

  • 40. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.
    Clin Rheumatol; 2003 Oct 22; 22(4-5):271-8. PubMed ID: 14576989
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.